Showing results (531-540 of 583) with videos related to
Sort By:
Pageof 59
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive ratsVirginija Jazbutyte, Kai Hu, Patricia Kruchten, et al.Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.Journal of Nursing Care Quality|November 28, 2018
Blended Facilitation as an Effective Implementation Strategy for Quality Improvement and Research in Nursing HomesCamilla B Pimentel, Whitney L Mills, Jennifer A Palmer, et al.Scientific Reports|October 6, 2020
Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infectionXabier Murgia, Andreas M Kany, Christian Herr, et al.BMC Geriatrics|April 28, 2021
Enhancing sleep quality for nursing home residents with dementia: a pragmatic randomized controlled trial of an evidence-based frontline huddling programA Lynn Snow, Julia Loup, Robert O Morgan, et al.Chemmedchem|August 18, 2017
Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel AntimycobacterialsChristian Brengel, Andreas Thomann, Alexander Schifrin, et al.Bioorganic Chemistry|November 4, 2020
Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitorsMohammad Abdel-Halim, Heather Tinsley, Adam B Keeton, et al.Journal of the American Medical Directors Association|March 11, 2019
Nursing Home Staff Perceptions of Barriers and Facilitators to Implementing a Quality Improvement InterventionWhitney L Mills, Camilla B Pimentel, A Lynn Snow, et al.Archiv Der Pharmazie|July 12, 2002
Inhibition of CYP 17, a new strategy for the treatment of prostate cancerRolf W Hartmann, Peter B Ehmer, Samer Haidar, et al.Journal of Medicinal Chemistry|November 28, 2018
Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis TherapyLorenz Siebenbuerger, Victor Hernandez-Olmos, Ahmed S Abdelsamie, et al.Pageof 59